Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mycophenolate mofetil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 97 for your search:
Start Over
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-Based Immunosuppressive Protocol
Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684
Stem Cell Transplant for Bone Marrow Failure Syndromes
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1813.00, NCI-2009-01532, P30CA015704, P01CA078902, FHCRC-1813.00, 5666, NCT00075478
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1992.00, NCI-2010-00737, P01CA078902, K23HL084054, P01CA018029, P01HL036444, FHCRC-1992.00, 6170, NHLBI-K23-HL084054-01A1, NCT00322101
Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 467, 2U01HL069294, BMTCTN-0501, FHCRC-2128.00, NCT00412360
Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 669, U01HL069294, BMT CTN 0802, U01 HL069294-06, NCT01002742
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 55
Sponsor: NCI, Other
Protocol IDs: 06-125, MSKCC-06125, NCT00423514
Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 30 and under
Sponsor: Other
Protocol IDs: L 9471, NCT00529360
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2008.095, NCT00810602
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 1383.00, NCI-2012-00670, P01CA078902, FHCRC-1383.00, NCI-G99-1538, NCT00003954
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1495.00, NCI-2012-00581, P30CA015704, FHCRC-1495.00, NCI-G00-1790, NCT00005851
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1533.00, NCI-2013-01634, P01CA078902, P30CA015704, FHCRC-1533.00, NCI-H00-0062, NCT00006251
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1668.00, NCI-2012-00668, P30CA015704, P01CA018029, FHCRC-1668.00, NCT00078858
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: 1586.00, FHCRC-1586.00, NCI-H01-0080, CDR0000069042, NCT00027547
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1641.00, NCI-2012-00591, P30CA015704, P01CA018029, FHCRC-1641.00, NCI-H01-0081, NCT00027820
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 1743.00, NCI-2011-00386, P30CA015704, FHCRC-1743.00, 5476, NCT00054353
Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1939.00, FHCRC-1939.00, CDR0000432959, 5987, NCT00119340
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000066639, J9845, R01CA067782, P30CA006973, JHOC-98070603, JHOC-9845, NCI-H98-0023, NCT00003572
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000068212, MSGCC-0012, NCI-V00-1624, NCT00006350
Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: 1581.00, NCI-2010-00131, P30CA015704, P01CA078902, FHCRC-1581.00, 5235, NCI-H02-0087, NCT00036738
Start Over